Document is current

Any future updates will be listed below

Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring

Crossref DOI link: https://doi.org/10.1007/s00280-017-3362-1

Published Online: 2017-06-30

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark